ArticleSmall methods2025
Fabrication of Microneedles by Pulsating In Situ Dried Electrostretching for Transdermal Drug Delivery.
Article in Small methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Living Materials Approach for In Situ Bio-Polymers Production Using Bacillus Paralicheniformis in Microneedles.Advanced healthcare materials · 2026Article
- Fabrication of Microneedles by Pulsating In Situ Dried Electrostretching for Transdermal Drug Delivery.Small methods · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
This paper introduces a novel pulsating in situ dried electrostretching (PIDES) technique for the fabrication of microneedles (MNs) for transdermal drug delivery. This method utilizes pulsed voltage to induce electrohydrodynamic forces that stretch and freeze a polymer droplet into a conical shape with a micrometer-scale tip. With the effects of solvent evaporation, the polymeric droplet is in situ stretched into a conical shape and solidified, transforming into a sharp MN, suitable for transdermal drug administration. Penetration and mechanical tests confirm that the MNs possess sufficient sharpness and strength for effective skin penetration applications. Additionally, curcumin loading and in vitro release tests with different concentrations demonstrate the MNs' ability to carry drugs and exhibit effective controlled release profiles. These findings highlight PIDES as a promising, low-cost, and simple approach for the development of painless and efficient transdermal drug delivery systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.